
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Transl Neurodegener</journal-id><journal-id journal-id-type="iso-abbrev">Transl Neurodegener</journal-id><journal-title-group><journal-title>Translational Neurodegeneration</journal-title></journal-title-group><issn pub-type="epub">2047-9158</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29296278</article-id><article-id pub-id-type="pmc">5738848</article-id><article-id pub-id-type="publisher-id">105</article-id><article-id pub-id-type="doi">10.1186/s40035-017-0105-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Clinical features of Parkinson&#x02019;s disease with and without rapid eye movement sleep behavior disorder</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Liu</surname><given-names>Ye</given-names></name><address><email>lewys@126.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Zhu</surname><given-names>Xiao-Ying</given-names></name><address><email>docxiaoying@163.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Xiao-Jin</given-names></name><address><email>kokolalazxj@163.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kuo</surname><given-names>Sheng-Han</given-names></name><address><email>sk3295@cumc.columbia.edu</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Ondo</surname><given-names>William G.</given-names></name><address><email>wondo1965@gmail.com</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wu</surname><given-names>Yun-Cheng</given-names></name><address><phone>86-21-36126171</phone><email>yunchw@medmail.com.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label>Department of Neurology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No.100, Haining Road, Shanghai, 200080 People&#x02019;s Republic of China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000000419368729</institution-id><institution-id institution-id-type="GRID">grid.21729.3f</institution-id><institution>Department of Neurology, </institution><institution>College of Physicians and Surgeons, Columbia University, </institution></institution-wrap>New York, USA </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">000000041936877X</institution-id><institution-id institution-id-type="GRID">grid.5386.8</institution-id><institution>Methodist Neurological Institute, </institution></institution-wrap>Houston, TX USA </aff></contrib-group><pub-date pub-type="epub"><day>21</day><month>12</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>21</day><month>12</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>6</volume><elocation-id>35</elocation-id><history><date date-type="received"><day>17</day><month>8</month><year>2017</year></date><date date-type="accepted"><day>4</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Rapid eye movement sleep behavior disorder (RBD) and Parkinson&#x02019;s disease (PD) are two distinct clinical diseases but they share some common pathological and anatomical characteristics. This study aims to confirm the clinical features of RBD in Chinese PD patients.</p></sec><sec><title>Methods</title><p id="Par2">One hundred fifty PD patients were enrolled from the Parkinson`s disease and Movement Disorders Center&#x000a0;in&#x000a0; Department of Neurology, Shanghai General Hospital from January 2013 to August 2014. This study examined PD patients with or without RBD as determined by the REM Sleep Behavior Disorder Screening Questionnaire (RBDSQ), assessed motor subtype by Unified PD Rating Scale (UPDRS) III at &#x0201c;on&#x0201d; state, and compared the sub-scale scores representing tremor, rigidity, appendicular and axial. Investigators also assessed the Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD), Mini-Mental State Examination (MMSE), Clinical Dementia Rating (CDR), and Parkinson&#x02019;s disease Sleep Scale (PDSS).</p></sec><sec><title>Results</title><p id="Par3">One hundred fourty one PD patients entered the final study. 30 (21.28%) PD patients had probable RBD (pRBD) diagnosed with a RBDSQ score of 6 or above. There were no significant differences for age, including age of PD onset and PD duration, gender, smoking status, alcohol or coffee use, presence of anosmia or freezing, UPDRS III, and H-Y stages between the pRBD<sup>+</sup> and pRBD<sup>&#x02212;</sup> groups. pRBD<sup>+</sup> group had lower MMSE scores, higher PDSS scores, and pRBD<sup>+</sup> PD patients had more prominent proportion in anxiety, depression, constipation, hallucination and a greater prevalence of orthostatic hypotension.</p></sec><sec><title>Conclusion</title><p id="Par4">pRBD<sup>+</sup> PD patients exhibited greater changes in non-motor symptoms. However, there was no increase in motor deficits.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Rapid eye movement sleep behavior disorder</kwd><kwd>Parkinson&#x02019;s disease</kwd><kwd>Depression</kwd><kwd>Cognitive decline</kwd><kwd>Orthostatic hypotension</kwd><kwd>Motor deficits</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81671251</award-id><award-id>81371410</award-id><principal-award-recipient><name><surname>Wu</surname><given-names>Yun-Cheng</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution>Biomedical Multidisciplinary Program of Shanghai Jiao Tong University</institution></funding-source><award-id>YG2014MS31</award-id><principal-award-recipient><name><surname>Wu</surname><given-names>Yun-Cheng</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par24">Rapid eye movement sleep (REM) is characterized by decreased or absent muscle tone (atonia), desynchronization of the electroencephalogram, with the presence of saw tooth waves, and autonomic instability. Rapid eye movement sleep behavior disorder (RBD) is a form of parasomnia during which patients develop limb or body movements, which correlate with dream enactment behavior. The abnormal physiology of RBD is loss of muscle atonia (paralysis) during otherwise intact REM sleep [<xref ref-type="bibr" rid="CR1">1</xref>].</p><p id="Par25">The standard RBD diagnostic criteria are based on the 2nd edition of the International Classification of Sleep Disorders (ICSD) [<xref ref-type="bibr" rid="CR2">2</xref>], and polysomnology (PSG) is necessary for a definitive diagnosis. Nomura et al., determined that RBD rapid screening questionnaire (RBDSQ), which is completed by the patient, had a sensitivity of 84.2% and specificity of 96.2% to diagnose RBD when compared with standard RBD diagnostic criteria using PSG in PD at a cut off of 6 points (total score of RBDSQ is 13, and a score of 5 is the cut-off point for healthy individuals) [<xref ref-type="bibr" rid="CR3">3</xref>]. Chahine et al. investigated the use of the RBDSQ plus Mayo Sleep questionnaire 1 (MSQ1) compared with PSG in PD patients. They found sensitivity was highest when the questionnaires were used in combination while specificity was highest for the RBDSQ used alone at a cut-off point of 7 [<xref ref-type="bibr" rid="CR4">4</xref>]. Shen SS used the RBDSQ to diagnose RBD in Chinese patients, compared with PSG, and found a cutoff points at 6 had the best specificity and sensitivity [<xref ref-type="bibr" rid="CR5">5</xref>].</p><p id="Par26">RBD has a close relationship with neurodegenerative diseases, especially those with &#x003b1;-synucleinopathy pathology such as PD, dementia with Lewy bodies (DLB) and multiple system atrophy (MSA) [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Recently, studies have indicated that PD patients with RBD might have some specific clinical features more commonly than those without RBD. Although data is mixed, PD patients with RBD have been reported to have worse decision-making [<xref ref-type="bibr" rid="CR7">7</xref>], cognitive impairment [<xref ref-type="bibr" rid="CR6">6</xref>], freezing, falls and rigidity [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. They also have a higher prevalence of orthostatic hypotension (OH) [<xref ref-type="bibr" rid="CR8">8</xref>] and visual hallucinations (VH) [<xref ref-type="bibr" rid="CR10">10</xref>]. However, there are no detailed data in PD patients with RBD in China. In this paper, we investigated the clinical features of PD patients with RBD in a tertiary referral center in China. The present study focused on the characteristics of motor and non-motor symptoms of PD with RBD compared to PD without RBD.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Patient selection</title><p id="Par27">One hundred fifty PD patients were enrolled from the Parkinson&#x02019;s disease and Movement Disorder Center in the Department of Neurology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China from January 2013 to August 2014. The diagnosis of PD was made by two movement disorder specialists according to the UK Parkinson&#x02019;s Disease Society (UKPDS) Brain Bank Criteria. Patients with severe dementia (CDR&#x02009;&#x02265;&#x02009;2), or other central nervous system disorders were excluded from this study. The study was approved by the Institution&#x02019;s Ethics Committee and all recruited patients consented to participate in the study.</p></sec><sec id="Sec4"><title>Patient evaluation</title><p id="Par28">Of 150 patients, 5 patients were excluded because of probable DLB, 3 patients had probable MSA, and 1 patient had vascular Parkinsonism. A total of 141 patients were enrolled in the study. Patient evaluation was performed by movement disorder specialists. Parkinsonism staging was evaluated according to the Hoehn &#x00026; Yahr staging scale. Part III of the Unified PD Rating Scale (UPDRS III) was performed during the &#x0201c;on&#x0201d; state. Motor subtype was analyzed by predominance of tremor or rigidity (UPDRS sub-scores) and predominance of limb or axial features (UPDRS sub-scores) [<xref ref-type="bibr" rid="CR9">9</xref>], Hamilton Anxiety Scale (HAMA; cut-off point &#x02265;8), Hamilton depression Scale (HAMD; cut-off point &#x02265;8) and Mini-Mental State Examination (MMSE) were used to evaluate the patient&#x02019;s mood and cognitive state. The patients whose MMSE score was lower than 17 (illiteracy) or lower than 20 (primary school level) or 24 (higher than middle school cultural level) [<xref ref-type="bibr" rid="CR11">11</xref>] were considered to have dementia and were evaluated using the Clinical Dementia Rating (CDR). Patients whose CDR was higher than 2 were excluded from the study. Investigators used the REM Sleep Behavior Disorder Screening Questionnaire(RBDSQ)to detect clinical probable RBD (pRBD). We set the RBDSQ cut-off point at a score of 6 according to the highest sensitivity and specificity determined by a previous study [<xref ref-type="bibr" rid="CR5">5</xref>]. The Parkinson&#x02019;s disease Sleep Scale (PDSS) was used to evaluate patient&#x02019;s sleep quality. Orthostatic hypotension (OH) was screened using a simple question:&#x0201c;Do you feel dizziness or weakness when you stand up?&#x0201d; If the answer was &#x0201c;yes&#x0201d;, a blood pressure test from the supine to standing position was checked, a fall in systolic blood pressure of &#x02265;20&#x000a0;mmHg, or in diastolic blood pressure of &#x02265;10&#x000a0;mmHg, was diagnosed as OH. Other items including smoking, alcohol and coffee consumption, hyposmia or anosmia, constipation were also documented by question. Patients continued with their prescribed treatment regimen, they used anti-Parkinson drugs, anti-hypnotics or anti-depressants as necessary.</p></sec><sec id="Sec5"><title>Statistical analysis</title><p id="Par29">The data were analyzed using the Statistical Package for Social Sciences (SPSS) 19(IBM Co., USA). The data is presented as mean, counts and percentages, and the adjusted difference in means. Analysis of descriptive variables was performed using two-tailed t tests. Mann-Whitney U tests and X<sup>2</sup> tests were used where appropriate. A P-P plot was used to test normal distribution. A <italic>p</italic> value &#x0003c;0.05 was considered to be significant.</p></sec></sec><sec id="Sec6"><title>Results</title><sec id="Sec7"><title>Demographics</title><p id="Par30">Among 141 patients, 74 were male (52.48%): 18 male (60%) in pRBD<sup>+</sup> group, and 56 male (50.45%) in pRBD<sup>&#x02212;</sup> group (<italic>p</italic>&#x02009;=&#x02009;0.655). Thirty patients (21.28%) were diagnosed with probable RBD (pRBD) based on a RBD screening questionnaire score&#x02009;&#x02265;&#x02009;6. If the cut-off score was set at 7 or 5, the incidence of RBD was 17.02% and 26.24% respectively, with little difference in the clinical features (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). The mean age in the pRBD<sup>+</sup> group was 68.33&#x02009;&#x000b1;&#x02009;8.76 versus 69.32&#x02009;&#x000b1;&#x02009;9.75&#x000a0;years in the pRBD<sup>&#x02212;</sup> group (<italic>p</italic>&#x02009;=&#x02009;0.618). Mean PD duration years is 4.13&#x02009;&#x000b1;&#x02009;4.216 in pRBD<sup>+</sup> and 4.65&#x02009;&#x000b1;&#x02009;3.570 in pRBD<sup>&#x02212;</sup> group (<italic>p</italic>&#x02009;=&#x02009;0.5). Smoking, alcohol and coffee consumption were infrequent in both groups (NS). There was no difference between the numbers of patients who took levodopa or dopamine agonists, and the levodopa equivalent dosage was similar in both groups. However, the pRBD<sup>+</sup> group had greater antidepressant and anti-hypnotic use (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Epidemiological characteristic of PD patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>pRBD+</th><th>pRBD-</th><th>
<italic>p</italic>
</th></tr></thead><tbody><tr><td>Patients number (<italic>n</italic>)</td><td>30</td><td>111</td><td/></tr><tr><td>Age (yr)</td><td>68.33&#x02009;&#x000b1;&#x02009;8.76</td><td>69.32&#x02009;&#x000b1;&#x02009;9.75</td><td>0.618</td></tr><tr><td>PD duration (yr)</td><td>4.13&#x02009;&#x000b1;&#x02009;4.22</td><td>4.65&#x02009;&#x000b1;&#x02009;3.57</td><td>0.500</td></tr><tr><td>Gender, male, <italic>n</italic> (%)</td><td>18 (60.00)</td><td>56 (50.45)</td><td>0.655</td></tr><tr><td>Smoking, <italic>n</italic> (%)</td><td>4 (13.3)</td><td>11 (9.91)</td><td>0.525</td></tr><tr><td>Alcohol, <italic>n</italic> (%)</td><td>0</td><td>9 (8.11)</td><td>0.204</td></tr><tr><td>Coffee, <italic>n</italic> (%)</td><td>1 (3.33)</td><td>5 (4.50)</td><td>1.0</td></tr><tr><td>Levodopa dose equivalent (mg/day)</td><td>353.53&#x02009;&#x000b1;&#x02009;236.10</td><td>339.10&#x02009;&#x000b1;&#x02009;272.08</td><td>0.531</td></tr><tr><td>Levodopa dose (mg/day)</td><td>325.00&#x02009;&#x000b1;&#x02009;205.84</td><td>285.15&#x02009;&#x000b1;&#x02009;250.09</td><td>0.221</td></tr><tr><td>Levodopa years</td><td>2.59&#x02009;&#x000b1;&#x02009;3.08</td><td>3.03&#x02009;&#x000b1;&#x02009;3.31</td><td>0.577</td></tr><tr><td>Dopa agonist dose (mg/day)</td><td>38.23&#x02009;&#x000b1;&#x02009;51.01</td><td>33.19&#x02009;&#x000b1;&#x02009;45.12</td><td>0.931</td></tr><tr><td>Dopa agonist years</td><td>0.91&#x02009;&#x000b1;&#x02009;1.52</td><td>4.41&#x02009;&#x000b1;&#x02009;29.21</td><td>0.479</td></tr><tr><td>TCA(Deanxit), <italic>n</italic> (%)</td><td>1 (0.033)</td><td>1 (0.009)</td><td>&#x0003e;0.90</td></tr><tr><td>Trihexyphenidyl, <italic>n</italic> (%)</td><td>4 (0.133)</td><td>18 (0.162)</td><td>&#x0003e;0.90</td></tr><tr><td>SSRI, <italic>n</italic> (%)</td><td>2 (0.067)</td><td>3 (0.027)</td><td>&#x0003e;0.75</td></tr><tr><td>BNZ, <italic>n</italic> (%)</td><td>6 (0.2)</td><td>3 (0.027)</td><td>&#x0003c;0.005</td></tr></tbody></table><table-wrap-foot><p>
<italic>SSRI</italic> Selective Serotonin Reuptake Inhibitor</p><p>
<italic>BNZ</italic> Benzodiazepines, n: number</p><p>The age, mean PD duration years, smoking, alcohol and coffee consumption rates, levodopa had no difference between two groups. However, the pRBD<sup>+</sup> group had greater antidepressant and antihypnotic use</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec8"><title>Non-motor symptoms</title><p id="Par31">pRBD<sup>+</sup> PD patients had significantly higher rates of anxiety (60% vs 22.52%, &#x0003c;0.001) and depression (63.33% vs 24.32%,<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>), and a higher mean PDSS score (17.50&#x02009;&#x000b1;&#x02009;9.60 vs 11.70&#x02009;&#x000b1;&#x02009;8.55, p&#x02009;&#x0003c;&#x02009;0.001) (Table <xref rid="Tab2" ref-type="table">2</xref>). The pRBD<sup>+</sup> group had lower mean MMSE score (25.30&#x02009;&#x000b1;&#x02009;3.91 vs. 26.75&#x02009;&#x000b1;&#x02009;3.97, <italic>p</italic>&#x02009;=&#x02009;0.017) (Table <xref rid="Tab3" ref-type="table">3</xref>). When educational status was taken into account, a diagnosis of dementia was not significantly difference between two groups (16.67% vs 11.71%, <italic>p</italic>&#x02009;=&#x02009;0.538) (Table <xref rid="Tab2" ref-type="table">2</xref>). Constipation and OH were more prominent in the pRBD<sup>+</sup> group (Table <xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Clinical characteristics of PD patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>pRBD+</th><th>pRBD-</th><th>
<italic>p</italic>
</th></tr></thead><tbody><tr><td>Hoehn &#x00026; Yahr stage</td><td>2.40&#x02009;&#x000b1;&#x02009;0.90</td><td>2.26&#x02009;&#x000b1;&#x02009;0.90</td><td>0.299</td></tr><tr><td>UPDRS III(total)</td><td>26.93&#x02009;&#x000b1;&#x02009;14.62</td><td>23.68&#x02009;&#x000b1;&#x02009;15.93</td><td>0.174</td></tr><tr><td>Bradykinesia (23&#x02013;26)</td><td>8.87&#x02009;&#x000b1;&#x02009;7.05</td><td>7.40&#x02009;&#x000b1;&#x02009;6.11</td><td>0.292</td></tr><tr><td>Freezing, <italic>n</italic> (%)</td><td>8 (26.7)</td><td>25 (22.52)</td><td>0.750</td></tr><tr><td>LcompareA</td><td>5.67&#x02009;&#x000b1;&#x02009;4.22</td><td>6.17&#x02009;&#x000b1;&#x02009;4.61</td><td>0.734</td></tr><tr><td>RcompareT</td><td>3.01&#x02009;&#x000b1;&#x02009;4.06</td><td>1.79&#x02009;&#x000b1;&#x02009;2.08</td><td>0.320</td></tr><tr><td>PDSS</td><td>17.50&#x02009;&#x000b1;&#x02009;9.60</td><td>11.70&#x02009;&#x000b1;&#x02009;8.55</td><td>&#x0003c;0.001</td></tr><tr><td>MMSE</td><td>25.30&#x02009;&#x000b1;&#x02009;3.91</td><td>26.75&#x02009;&#x000b1;&#x02009;3.97</td><td>0.017</td></tr><tr><td>HAMA</td><td>7.53&#x02009;&#x000b1;&#x02009;5.51</td><td>4.53&#x02009;&#x000b1;&#x02009;6.38</td><td>0.002</td></tr><tr><td>HAMD</td><td>10.83&#x02009;&#x000b1;&#x02009;8.60</td><td>5.39&#x02009;&#x000b1;&#x02009;7.12</td><td>&#x0003c;0.001</td></tr><tr><td>Hallucination, <italic>n</italic> (%)</td><td>6 (20.00)</td><td>7 (6.30)</td><td>0.032</td></tr><tr><td>Dementia, <italic>n</italic> (%)</td><td>5(16.67)</td><td>13(11.71)</td><td>0.538</td></tr><tr><td>Anxiety, <italic>n</italic> (%)</td><td>18 (60.00)</td><td>25 (22.52)</td><td>&#x0003c;0.001</td></tr><tr><td>Depression, <italic>n</italic> (%)</td><td>19 (63.33)</td><td>27 (24.32)</td><td>&#x0003c;0.001</td></tr><tr><td>Hyposmia, %</td><td>46.67</td><td>35.16</td><td>0.247</td></tr><tr><td>Constipation, %</td><td>80.00</td><td>57.66</td><td>0.033</td></tr><tr><td>Orthostatic hypotension, <italic>n</italic> (%)</td><td>7 (23.33)</td><td>7 (6.30)</td><td>0.012</td></tr></tbody></table><table-wrap-foot><p>LcompareA (UPDRS III): UPDRS score in limb compare with axial; RcompareT (UPDRS III): UPDRS score in rigidity compare with tremor; <italic>n</italic> Number</p><p>The pRBD<sup>+</sup> PD patients had significantly higher rates of anxiety, depression and visual hallucinations rates. And they had a higher mean PDSS score. Dementia was not significantly difference between two groups. Constipation and OH were more prominent in the pRBD<sup>+</sup> group</p></table-wrap-foot></table-wrap>
<table-wrap id="Tab3"><label>Table 3</label><caption><p>The clinical difference of RBD<sup>+</sup> vs RBD<sup>&#x02212;</sup> patients while RBDSQ cutoff at 7, 6 and 5 in present study</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>7 score</th><th>6 score</th><th>5 score</th></tr></thead><tbody><tr><td>RBD incidence, <italic>n</italic> (%)</td><td>24 (17.02)</td><td>30 (21.28)</td><td>37 (26.24)</td></tr><tr><td>Age</td><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td>PD duration</td><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td>Gender</td><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td>Dopamine use</td><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td>Hypnosmia</td><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td>Freezing</td><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td>Hallucination</td><td>+</td><td>+</td><td>&#x02013;</td></tr><tr><td>Constipation</td><td>+</td><td>+</td><td>+</td></tr><tr><td>HAMA</td><td>+</td><td>+</td><td>+</td></tr><tr><td>HAMD</td><td>+</td><td>+</td><td>+</td></tr><tr><td>PDSS</td><td>+</td><td>+</td><td>+</td></tr><tr><td>MMSE</td><td>+</td><td>+</td><td>+</td></tr><tr><td>Orthostatic hypotension</td><td>+</td><td>+</td><td>+</td></tr><tr><td>UPDRS III (total)</td><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td>Bradykinesia (23&#x02013;26)</td><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td>LcompareA</td><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td>RcompareT</td><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;</td></tr></tbody></table><table-wrap-foot><p>If the cut off score was set at 7, 6, or 5, the clinical features had little difference. If the cut off score was set at 5 score, the hallucination rates would have no difference in two groups instead. The other features were same in the three condition</p></table-wrap-foot></table-wrap>
</p><p id="Par32">There was no difference in the incidence of anosmia in pRBD<sup>+</sup> vs pRBD<sup>&#x02212;</sup> group (46.67% vs 35.16%, <italic>p</italic>&#x02009;=&#x02009;0.247) (Table <xref rid="Tab2" ref-type="table">2</xref>). From PDSS item 7, we found that there were 13 patients who had visual hallucinations, 20% (6) in pRBD<sup>+</sup> group and 6.3% (7) in pRBD<sup>&#x02212;</sup> group (<italic>p</italic>&#x02009;=&#x02009;0.032) (Table <xref rid="Tab2" ref-type="table">2</xref>).</p></sec><sec id="Sec9"><title>Motor symptoms</title><p id="Par33">The UPDRS III score was similar in the pRBD<sup>+</sup> and pRBD<sup>&#x02212;</sup> groups (26.93&#x02009;&#x000b1;&#x02009;14.62 vs 23.68&#x02009;&#x000b1;&#x02009;15.93, <italic>p</italic>&#x02009;=&#x02009;0.174). Mean H-Y stage was also similar between the two groups (2.40&#x02009;&#x000b1;&#x02009;0.90 vs 2.26&#x02009;&#x000b1;&#x02009;0.90, <italic>p</italic>&#x02009;=&#x02009;0.299). When limb scores in UPDRS III was compared with axial scores, the ratio showed no difference between pRBD<sup>+</sup> and pRBD<sup>&#x02212;</sup> groups (5.67&#x02009;&#x000b1;&#x02009;4.22 vs 6.17&#x02009;&#x000b1;&#x02009;4.61, <italic>p</italic>&#x02009;=&#x02009;0.734). When rigidity scores in UPDRS III were compared with resting tremor score, the ratio was also not significantly different (3.01&#x02009;&#x000b1;&#x02009;4.06 vs 1.79&#x02009;&#x000b1;&#x02009;2.08, <italic>p</italic>&#x02009;=&#x02009;0.32). Overall there was no difference between pRBD<sup>+</sup> group and pRBD<sup>&#x02212;</sup> group for motor severity and motor subtype (Table <xref rid="Tab2" ref-type="table">2</xref>). Freezing was also not different between the two groups (26.7% vs 22.52%, <italic>p</italic>&#x02009;=&#x02009;0.75).</p></sec></sec><sec id="Sec10"><title>Discussion</title><p id="Par34">Probable RBD is common in early PD and predicts future cognitive decline, particularly in attention and memory domains [<xref ref-type="bibr" rid="CR12">12</xref>]. The p<ext-link ext-link-type="uri" xlink:href="http://en.wikipedia.org/wiki/Pedunculopontine_nucleus">edunculopontine nucleus</ext-link> (PPN) and locus cerulean (LC)/ dorsal subcoeruleus (subCD) are compromised in both PD and RBD [<xref ref-type="bibr" rid="CR13">13</xref>&#x02013;<xref ref-type="bibr" rid="CR15">15</xref>]. Autopsy studies show that the loss of cholinergic neurons of the PPN in PD has a significant negative correlation with the modified Hoehn and Yahr stage [<xref ref-type="bibr" rid="CR16">16</xref>], and contribute to freezing and falls [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Dysfunction of the PPN relates to visual hallucination (VH) [<xref ref-type="bibr" rid="CR15">15</xref>]. A resting-state functional connectivity MRI (rs-fcMRI) study in RBD patient showed reduced connection between lateral geniculate nuclei LGN and visual association cortex [<xref ref-type="bibr" rid="CR18">18</xref>]. PD patients with probable RBD showed smaller volumes than patients without RBD and than healthy controls in the pontomesencephalic tegmentum where cholinergic, GABAergic and glutamatergic neurons are located. It is additionally associated with more widespread atrophy in other subcortical and cortical regions [<xref ref-type="bibr" rid="CR19">19</xref>]. The basal ganglia activity is changed across the sleep-wake cycle in RBD [<xref ref-type="bibr" rid="CR20">20</xref>]. The appearance of RBD in PD may be related to regional gray matter changes in the left posterior cingulate and hippocampus but not localized to the brain stem [<xref ref-type="bibr" rid="CR21">21</xref>].</p><p id="Par35">Our study had compared motor and non-motor symptoms in PD patients with and without RBD. The results were similar if we used a RBDSQ cut off point at 6 or 7 (Table <xref rid="Tab3" ref-type="table">3</xref>). Overall motor symptoms and signs were similar but we found significant difference between the two groups in many aspects of non-motor symptoms, including MMSE performance, visual hallucinations, depression, anxiety, orthostatic hypotension and constipation. Except for constipation, these results are consistent with most previous studies (detailed in Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>) [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR22">22</xref>&#x02013;<xref ref-type="bibr" rid="CR24">24</xref>]. Our findings are consistent with some studies that there are no difference between the motor symptoms [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR23">23</xref>], however, some previous studies indicated that pRBD+ patients showed much more worse in the gait, balance or increased dyskinesia (Table <xref rid="Tab4" ref-type="table">4</xref>) [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR25">25</xref>].<table-wrap id="Tab4"><label>Table 4</label><caption><p>Clinical features of PD with RBD patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Present study</th><th>Sixel-Doring 2014</th><th>Yoritaka 2009</th><th>Vibha 2011</th><th>Romenets 2012</th><th>Sommerauer 2014</th><th>Rolinski 2014</th></tr></thead><tbody><tr><td>Patients(<italic>n</italic>)</td><td>141</td><td>158</td><td>150</td><td>134</td><td>98</td><td>59</td><td>475</td></tr><tr><td>RCP</td><td>6</td><td>no</td><td>
<sup>b</sup>
</td><td>
<sup>b</sup>
</td><td>no</td><td>no</td><td>5</td></tr><tr><td>RBD (%)</td><td>21.28</td><td>51.27</td><td>&#x02013;</td><td>19.4</td><td>&#x02013;</td><td>&#x02013;</td><td>47.2</td></tr><tr><td>Male pro</td><td>&#x02013;</td><td>&#x02013;</td><td>+</td><td>&#x02013;</td><td>+</td><td>&#x02013;</td><td>+</td></tr><tr><td>older</td><td>&#x02013;</td><td>&#x02013;</td><td>+</td><td>&#x02013;</td><td>+</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td>MMSE</td><td>+</td><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;</td><td>no</td><td>no</td><td>+</td></tr><tr><td>PDSS</td><td>+</td><td>no</td><td>no</td><td>+</td><td>no</td><td>no</td><td>
<sup>a</sup>
</td></tr><tr><td>Depression/anxiety</td><td>+</td><td>no</td><td>no</td><td>&#x02013;</td><td>+</td><td>no</td><td>+</td></tr><tr><td>Dementia</td><td>&#x02013;</td><td>no</td><td>&#x02013;</td><td>no</td><td>ex</td><td>no</td><td>+</td></tr><tr><td>Hallucination</td><td>+</td><td>no</td><td>&#x02013;</td><td>+</td><td>&#x02013;</td><td>no</td><td>+</td></tr><tr><td>N-Tremor prominent</td><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;</td><td>+</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td>Axial/limb ratio</td><td>&#x02013;</td><td>&#x02013;</td><td>no</td><td>no</td><td>&#x02013;</td><td>no</td><td>+</td></tr><tr><td>Constipation</td><td>+</td><td>no</td><td>+</td><td>no</td><td>&#x02013;</td><td>no</td><td>+</td></tr><tr><td>Hyposmia</td><td>&#x02013;</td><td>&#x02013;</td><td>no</td><td>no</td><td>&#x02013;</td><td>no</td><td>&#x02013;</td></tr><tr><td>OH</td><td>+</td><td>no</td><td>&#x02013;</td><td>no</td><td>+</td><td>no</td><td>+</td></tr><tr><td>PSG</td><td>N</td><td>Y</td><td>N</td><td>N</td><td>Y</td><td>Y</td><td>N</td></tr></tbody></table><table-wrap-foot><p>-: no difference, +: significant difference</p><p>Ex: dementia patient was excluded</p><p>
<italic>Male pro</italic> Male prominent</p><p>No: no data</p><p>
<sup>a</sup>Rolinski use Epworth Sleeping Scale instead of PDSS, difference is significant</p><p>
<sup>b</sup>Yoritaka and Vibha use minimum clinical criteria of ICSD for RBD diagnosis instead</p><p>
<italic>N</italic> No</p><p>
<italic>N-tremor prominent</italic> Non-tremor prominent</p><p>
<italic>OH</italic> Orthostatic hypotension</p><p>
<italic>Y</italic> Yes</p><p>
<italic>RCP</italic> RBDSQ cutoff points</p><p>Overall motor symptoms and signs were similar but we found significant difference between the two groups in many aspects of non-motor symptoms, including MMSE performance, visual hallucinations, depression, anxiety, orthostatic hypotension and constipation. Except for constipation, these results are consistent with most previous studies</p></table-wrap-foot></table-wrap>
</p><p id="Par36">In summary, this study systematically investigated the clinical features of PD patients with RBD. There are several potential weaknesses. We used the RBDSQ to detect RBD in PD patients which is easier and more readily available than PSG. The sample size is relatively small and it might have given false negatives and false positives for diagnosing RBD without PSG. We diagnosed the patient with anosmia and constipation only based on self-report and not using objective examination. Neurological image and electrophysiology will be valuable for further study.</p></sec><sec id="Sec11"><title>Conclusions</title><p id="Par37">The present study demonstrated that there were no significant differences in motor deficits in pRBD<sup>+</sup> PD patients, while the non-motor symptoms are prominent, such as mood, sleep, constipation, cognition and orthostatic hypotension. However, further studies and laboratory tests are needed to improve the understanding of RBD in PD.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>CDR</term><def><p id="Par5">Clinical Dementia Rating</p></def></def-item><def-item><term>DLB</term><def><p id="Par6">Dementia with Lewy bodies</p></def></def-item><def-item><term>HAMA</term><def><p id="Par7">Hamilton Anxiety Scale</p></def></def-item><def-item><term>HAMD</term><def><p id="Par8">Hamilton Depression Scale</p></def></def-item><def-item><term>ICSD</term><def><p id="Par9">International Classification of Sleep Disorders</p></def></def-item><def-item><term>LC</term><def><p id="Par10">Locus cerulean</p></def></def-item><def-item><term>MMSE</term><def><p id="Par11">Mini-Mental State Examination</p></def></def-item><def-item><term>MSA</term><def><p id="Par12">Multiple system atrophy</p></def></def-item><def-item><term>MSQ1</term><def><p id="Par13">Mayo Sleep questionnaire 1</p></def></def-item><def-item><term>OH</term><def><p id="Par14">Orthostatic hypotension</p></def></def-item><def-item><term>PD</term><def><p id="Par15">Parkinson&#x02019;s disease</p></def></def-item><def-item><term>PDSS</term><def><p id="Par16">Parkinson&#x02019;s disease Sleep Scale</p></def></def-item><def-item><term>PPN</term><def><p id="Par17">Pedunculopontine nucleus</p></def></def-item><def-item><term>pRBD</term><def><p id="Par18">Probable RBD</p></def></def-item><def-item><term>PSG</term><def><p id="Par19">Polysomnology</p></def></def-item><def-item><term>RBD</term><def><p id="Par20">Rapid eye movement sleep behavior disorder</p></def></def-item><def-item><term>RBDSQ</term><def><p id="Par21">REM Sleep Behavior Disorder Screening Questionnaire</p></def></def-item><def-item><term>subCD</term><def><p id="Par22">Dorsal subcoeruleus</p></def></def-item><def-item><term>VH</term><def><p id="Par23">Visual hallucinations</p></def></def-item></def-list></glossary><fn-group><fn><p>Ye Liu and Xiao-Ying Zhu are co-first authors</p></fn></fn-group><ack><p>This work was supported by the National Natural Science Foundation of China (NSFC) (81171205, 81371410) and the Biomedical Multidisciplinary Program of Shanghai Jiao Tong University (YG2014MS31, YG2015QN21, YG2016QN25).</p><sec id="FPar1"><title>Funding</title><p id="Par38">National Natural Science Foundation of China, Biomedical Multidisciplinary Program of Shanghai Jiao Tong University.</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p id="Par39">All the data mentioned in this article are available on published article.</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>YL, X-YZ and Y-CW mainly designed and drafted the manuscript. WGO and Y-CW were involved in critically revising the manuscript and provided intellectual thoughts. X-JZ attended the survey. S-HK modified the manuscript. All authors read and approved the final manuscript to be published.</p></notes><notes notes-type="COI-statement"><sec id="FPar3"><title>Ethics approval and consent to participate</title><p id="Par40">Ethics approval was permitted by ethics committee of Shanghai Jiao Tong University affiliated Shanghai General Hospital. Approval paper number is 2015KY128. The consents to participate are stored in Ethics office.</p></sec><sec id="FPar4"><title>Consent for publication</title><p id="Par41">Not applicable.</p></sec><sec id="FPar5"><title>Competing interests</title><p id="Par42">The authors declare that they have no competing interests.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frenette</surname><given-names>E</given-names></name></person-group><article-title>REM sleep behavior disorder</article-title><source>Med Clin North Am</source><year>2010</year><volume>94</volume><fpage>593</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1016/j.mcna.2010.02.010</pub-id><pub-id pub-id-type="pmid">20451035</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sateia</surname><given-names>MJ</given-names></name></person-group><article-title>International classification of sleep disorders-third edition: highlights and modifications</article-title><source>Chest</source><year>2014</year><volume>146</volume><fpage>1387</fpage><lpage>1394</lpage><pub-id pub-id-type="doi">10.1378/chest.14-0970</pub-id><pub-id pub-id-type="pmid">25367475</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nomura</surname><given-names>T</given-names></name><name><surname>Inoue</surname><given-names>Y</given-names></name><name><surname>Kagimura</surname><given-names>T</given-names></name><name><surname>Uemura</surname><given-names>Y</given-names></name><name><surname>Nakashima</surname><given-names>K</given-names></name></person-group><article-title>Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson's disease patients</article-title><source>Sleep Med</source><year>2011</year><volume>12</volume><fpage>711</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1016/j.sleep.2011.01.015</pub-id><pub-id pub-id-type="pmid">21700495</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chahine</surname><given-names>LM</given-names></name><name><surname>Daley</surname><given-names>J</given-names></name><name><surname>Horn</surname><given-names>S</given-names></name><name><surname>Colcher</surname><given-names>A</given-names></name><name><surname>Hurtig</surname><given-names>H</given-names></name><name><surname>Cantor</surname><given-names>C</given-names></name><name><surname>Dahodwala</surname><given-names>N</given-names></name></person-group><article-title>Questionnaire-based diagnosis of REM sleep behavior disorder in Parkinson's disease</article-title><source>Mov Disord</source><year>2013</year><volume>28</volume><fpage>1146</fpage><lpage>1149</lpage><pub-id pub-id-type="doi">10.1002/mds.25438</pub-id><pub-id pub-id-type="pmid">23519694</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>SS</given-names></name><name><surname>Liu</surname><given-names>CF</given-names></name></person-group><source>[validation study of related questionnaires of REM sleep behavior disorder]. Graduation dissertation</source><year>2012</year><publisher-loc>China</publisher-loc><publisher-name>Soochow Universtiy</publisher-name></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vendette</surname><given-names>M</given-names></name><name><surname>Gagnon</surname><given-names>JF</given-names></name><name><surname>Decary</surname><given-names>A</given-names></name><name><surname>Massicotte-Marquez</surname><given-names>J</given-names></name><name><surname>Postuma</surname><given-names>RB</given-names></name><name><surname>Doyon</surname><given-names>J</given-names></name><name><surname>Panisset</surname><given-names>M</given-names></name><name><surname>Montplaisir</surname><given-names>J</given-names></name></person-group><article-title>REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia</article-title><source>Neurology</source><year>2007</year><volume>69</volume><fpage>1843</fpage><lpage>1849</lpage><pub-id pub-id-type="doi">10.1212/01.wnl.0000278114.14096.74</pub-id><pub-id pub-id-type="pmid">17984452</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delazer</surname><given-names>M</given-names></name><name><surname>Hogl</surname><given-names>B</given-names></name><name><surname>Zamarian</surname><given-names>L</given-names></name><name><surname>Wenter</surname><given-names>J</given-names></name><name><surname>Ehrmann</surname><given-names>L</given-names></name><name><surname>Gschliesser</surname><given-names>V</given-names></name><name><surname>Brandauer</surname><given-names>E</given-names></name><name><surname>Poewe</surname><given-names>W</given-names></name><name><surname>Frauscher</surname><given-names>B</given-names></name></person-group><article-title>Decision making and executive functions in REM sleep behavior disorder</article-title><source>Sleep</source><year>2012</year><volume>35</volume><fpage>667</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.5665/sleep.1828</pub-id><pub-id pub-id-type="pmid">22547893</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romenets</surname><given-names>SR</given-names></name><name><surname>Gagnon</surname><given-names>JF</given-names></name><name><surname>Latreille</surname><given-names>V</given-names></name><name><surname>Panniset</surname><given-names>M</given-names></name><name><surname>Chouinard</surname><given-names>S</given-names></name><name><surname>Montplaisir</surname><given-names>J</given-names></name><name><surname>Postuma</surname><given-names>RB</given-names></name></person-group><article-title>Rapid eye movement sleep behavior disorder and subtypes of Parkinson's disease</article-title><source>Mov Disord</source><year>2012</year><volume>27</volume><fpage>996</fpage><lpage>1003</lpage><pub-id pub-id-type="doi">10.1002/mds.25086</pub-id><pub-id pub-id-type="pmid">22733427</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Postuma</surname><given-names>RB</given-names></name><name><surname>Gagnon</surname><given-names>JF</given-names></name><name><surname>Vendette</surname><given-names>M</given-names></name><name><surname>Charland</surname><given-names>K</given-names></name><name><surname>Montplaisir</surname><given-names>J</given-names></name></person-group><article-title>REM sleep behaviour disorder in Parkinson's disease is associated with specific motor features</article-title><source>J Neurol Neurosurg Psychiatry</source><year>2008</year><volume>79</volume><fpage>1117</fpage><lpage>1121</lpage><pub-id pub-id-type="doi">10.1136/jnnp.2008.149195</pub-id><pub-id pub-id-type="pmid">18682443</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Wan</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Xiao</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>JF</given-names></name><name><surname>Wang</surname><given-names>XJ</given-names></name><name><surname>Zhou</surname><given-names>HY</given-names></name><name><surname>Tan</surname><given-names>YY</given-names></name><name><surname>Cheng</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>SD</given-names></name></person-group><article-title>Visual hallucinations and associated factors in Chinese patients with Parkinson's disease: roles of RBD and visual pathway deficit</article-title><source>Parkinsonism Relat Disord</source><year>2010</year><volume>16</volume><fpage>695</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1016/j.parkreldis.2010.08.013</pub-id><pub-id pub-id-type="pmid">20833097</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>ZY</given-names></name><name><surname>Zhang</surname><given-names>MY</given-names></name><name><surname>Qiu</surname><given-names>GY</given-names></name><etal/></person-group><article-title>Clinical application of Chinese edition of mini-mental state examination</article-title><source>Shanghai Arch Psychiatry</source><year>1989</year><volume>7</volume><issue>3</issue><fpage>108</fpage><lpage>113</lpage></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chahine</surname><given-names>LM</given-names></name><name><surname>Xie</surname><given-names>SX</given-names></name><name><surname>Simuni</surname><given-names>T</given-names></name><name><surname>Tran</surname><given-names>B</given-names></name><name><surname>Postuma</surname><given-names>R</given-names></name><name><surname>Amara</surname><given-names>A</given-names></name><name><surname>Oertel</surname><given-names>WH</given-names></name><name><surname>Iranzo</surname><given-names>A</given-names></name><name><surname>Scordia</surname><given-names>C</given-names></name><name><surname>Fullard</surname><given-names>M</given-names></name><etal/></person-group><article-title>Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder</article-title><source>Parkinsonism Relat Disord</source><year>2016</year><volume>27</volume><fpage>102</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/j.parkreldis.2016.03.006</pub-id><pub-id pub-id-type="pmid">27010070</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benninger</surname><given-names>DH</given-names></name><name><surname>Michel</surname><given-names>J</given-names></name><name><surname>Waldvogel</surname><given-names>D</given-names></name><name><surname>Candia</surname><given-names>V</given-names></name><name><surname>Poryazova</surname><given-names>R</given-names></name><name><surname>van Hedel</surname><given-names>HJ</given-names></name><name><surname>Bassetti</surname><given-names>CL</given-names></name></person-group><article-title>REM sleep behavior disorder is not linked to postural instability and gait dysfunction in Parkinson</article-title><source>Mov Disord</source><year>2010</year><volume>25</volume><fpage>1597</fpage><lpage>1604</lpage><pub-id pub-id-type="doi">10.1002/mds.23121</pub-id><pub-id pub-id-type="pmid">20629146</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heister</surname><given-names>DS</given-names></name><name><surname>Hayar</surname><given-names>A</given-names></name><name><surname>Garcia-Rill</surname><given-names>E</given-names></name></person-group><article-title>Cholinergic modulation of GABAergic and glutamatergic transmission in the dorsal subcoeruleus: mechanisms for REM sleep control</article-title><source>Sleep</source><year>2009</year><volume>32</volume><fpage>1135</fpage><lpage>1147</lpage><pub-id pub-id-type="doi">10.1093/sleep/32.9.1135</pub-id><pub-id pub-id-type="pmid">19750918</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hepp</surname><given-names>DH</given-names></name><name><surname>Ruiter</surname><given-names>AM</given-names></name><name><surname>Galis</surname><given-names>Y</given-names></name><name><surname>Voorn</surname><given-names>P</given-names></name><name><surname>Rozemuller</surname><given-names>AJ</given-names></name><name><surname>Berendse</surname><given-names>HW</given-names></name><name><surname>Foncke</surname><given-names>EM</given-names></name><name><surname>van de Berg</surname><given-names>WD</given-names></name></person-group><article-title>Pedunculopontine cholinergic cell loss in hallucinating Parkinson disease patients but not in dementia with Lewy bodies patients</article-title><source>J Neuropathol Exp Neurol</source><year>2013</year><volume>72</volume><fpage>1162</fpage><lpage>1170</lpage><pub-id pub-id-type="doi">10.1097/NEN.0000000000000014</pub-id><pub-id pub-id-type="pmid">24226265</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rinne</surname><given-names>JO</given-names></name><name><surname>Ma</surname><given-names>SY</given-names></name><name><surname>Lee</surname><given-names>MS</given-names></name><name><surname>Collan</surname><given-names>Y</given-names></name><name><surname>Roytta</surname><given-names>M</given-names></name></person-group><article-title>Loss of cholinergic neurons in the pedunculopontine nucleus in Parkinson's disease is related to disability of the patients</article-title><source>Parkinsonism Relat Disord</source><year>2008</year><volume>14</volume><fpage>553</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1016/j.parkreldis.2008.01.006</pub-id><pub-id pub-id-type="pmid">18329941</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fling</surname><given-names>BW</given-names></name><name><surname>Cohen</surname><given-names>RG</given-names></name><name><surname>Mancini</surname><given-names>M</given-names></name><name><surname>Nutt</surname><given-names>JG</given-names></name><name><surname>Fair</surname><given-names>DA</given-names></name><name><surname>Horak</surname><given-names>FB</given-names></name></person-group><article-title>Asymmetric pedunculopontine network connectivity in parkinsonian patients with freezing of gait</article-title><source>Brain</source><year>2013</year><volume>136</volume><fpage>2405</fpage><lpage>2418</lpage><pub-id pub-id-type="doi">10.1093/brain/awt172</pub-id><pub-id pub-id-type="pmid">23824487</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geddes</surname><given-names>MR</given-names></name><name><surname>Tie</surname><given-names>Y</given-names></name><name><surname>Gabrieli</surname><given-names>JD</given-names></name><name><surname>McGinnis</surname><given-names>SM</given-names></name><name><surname>Golby</surname><given-names>AJ</given-names></name><name><surname>Whitfield-Gabrieli</surname><given-names>S</given-names></name></person-group><article-title>Altered functional connectivity in Lesional Peduncular Hallucinosis with REM sleep behavior disorder</article-title><source>Cortex</source><year>2016</year><volume>74</volume><fpage>96</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/j.cortex.2015.10.015</pub-id><pub-id pub-id-type="pmid">26656284</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boucetta</surname><given-names>S</given-names></name><name><surname>Salimi</surname><given-names>A</given-names></name><name><surname>Dadar</surname><given-names>M</given-names></name><name><surname>Jones</surname><given-names>BE</given-names></name><name><surname>Collins</surname><given-names>DL</given-names></name><name><surname>Dang-Vu</surname><given-names>TT</given-names></name></person-group><article-title>Structural brain alterations associated with rapid eye movement sleep behavior disorder in Parkinson's disease</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>26782</fpage><pub-id pub-id-type="doi">10.1038/srep26782</pub-id><pub-id pub-id-type="pmid">27245317</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tekriwal</surname><given-names>A</given-names></name><name><surname>Kern</surname><given-names>DS</given-names></name><name><surname>Tsai</surname><given-names>J</given-names></name><name><surname>Ince</surname><given-names>NF</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Thompson</surname><given-names>JA</given-names></name></person-group><article-title>Abosch a.REM sleep behaviour disorder: prodromal and mechanistic insights for Parkinson's disease</article-title><source>J Neurol Neurosurg Psychiatry</source><year>2017</year><volume>88</volume><issue>5</issue><fpage>445</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1136/jnnp-2016-314471</pub-id><pub-id pub-id-type="pmid">27965397</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>JS</given-names></name><name><surname>Shin</surname><given-names>SA</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Nam</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>YK</given-names></name></person-group><article-title>Neural substrates of rapid eye movement sleep behavior disorder in Parkinson's disease</article-title><source>Parkinsonism Relat Disord</source><year>2016</year><volume>23</volume><fpage>31</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.parkreldis.2015.11.027</pub-id><pub-id pub-id-type="pmid">26678512</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rolinski</surname><given-names>M</given-names></name><name><surname>Szewczyk-Krolikowski</surname><given-names>K</given-names></name><name><surname>Tomlinson</surname><given-names>PR</given-names></name><name><surname>Nithi</surname><given-names>K</given-names></name><name><surname>Talbot</surname><given-names>K</given-names></name><name><surname>Ben-Shlomo</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>MT</given-names></name></person-group><article-title>REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease</article-title><source>J Neurol Neurosurg Psychiatry</source><year>2014</year><volume>85</volume><fpage>560</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1136/jnnp-2013-306104</pub-id><pub-id pub-id-type="pmid">24187013</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vibha</surname><given-names>D</given-names></name><name><surname>Shukla</surname><given-names>G</given-names></name><name><surname>Goyal</surname><given-names>V</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Srivastava</surname><given-names>AK</given-names></name><name><surname>Behari</surname><given-names>M</given-names></name></person-group><article-title>RBD in Parkinson's disease: a clinical case control study from North India</article-title><source>Clin Neurol Neurosurg</source><year>2011</year><volume>113</volume><fpage>472</fpage><lpage>476</lpage><pub-id pub-id-type="doi">10.1016/j.clineuro.2011.02.007</pub-id><pub-id pub-id-type="pmid">21414715</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JE</given-names></name><name><surname>Kim</surname><given-names>KS</given-names></name><name><surname>Shin</surname><given-names>HW</given-names></name><name><surname>Sohn</surname><given-names>YH</given-names></name></person-group><article-title>Factors related to clinically probable REM sleep behavior disorder in Parkinson disease</article-title><source>Parkinsonism Relat Disord</source><year>2010</year><volume>16</volume><fpage>105</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1016/j.parkreldis.2009.08.005</pub-id><pub-id pub-id-type="pmid">19716333</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozekmekci</surname><given-names>S</given-names></name><name><surname>Apaydin</surname><given-names>H</given-names></name><name><surname>Kilic</surname><given-names>E</given-names></name></person-group><article-title>Clinical features of 35 patients with Parkinson's disease displaying REM behavior disorder</article-title><source>Clin Neurol Neurosurg</source><year>2005</year><volume>107</volume><fpage>306</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1016/j.clineuro.2004.09.021</pub-id><pub-id pub-id-type="pmid">15885389</pub-id></element-citation></ref></ref-list></back></article>